Revision: February 2020
Commonly requested panels are listed below, by kit name. When requesting a panel, please include the MLPA mix and version number (for example P088-C2). If the panel is not in the list, please contact tech_support@softgenetics.com. Many commonly used panels are also available in the Panel Editor of GeneMarker -- Tools - Panel Editor - File - Import Pre-defined Panels - MLPA folder.
Click here to request panels.
MLPA mix |
Known Syndrome / Disease |
Chromosomal Area / Genes |
|
ME001-Tumour suppressor mix 1 |
Tumour suppressor genes |
Various |
|
ME002-Tumour suppressor mix 2 |
Tumour suppressor genes |
Various |
|
ME003-Tumour suppressor mix 3 |
Tumour suppressor genes |
Various | |
ME004-Tumour suppresoor mix 4 |
Tumour suppressor genes |
Various |
|
ME011-MMR |
Mismatch repair genes(MMR) |
MLH1, MSH2, MSH6, MLH3, MSH3 | |
ME012-MGMT |
Aberrant methylation |
MGMT |
|
ME024-9p21 |
Tumours, Cutaneous melanoma |
9p21, CDKN2A, CDKNA2B |
|
ME029-FMR1/AFF2 |
Fragile X |
FMR1, AFF2 |
|
ME030-BWS/RSS |
Beckwith-Wiedemann |
11p15 region, H19, IGF2, | |
ME031-GNAS |
Albright hereditary osteodystrophy (AHO), Pseudohypoparathyroidism (PHP) |
GNAS 20q13.32 |
|
ME032-UPD7-UPD14 |
Aberrant methylation |
GRB10, MEG3, MEST, MIR380, PLAGL1 | |
ME034 |
Multi-locus Imprinting |
Various |
|
ME043-Lynch Syndrome |
Lynch syndrome |
MHL1, MSH2, CDKN2A, BRAF V600E | |
P002-BRCA1 |
Hereditary breast cancer |
17q21.31 |
|
P003-MLH1/MSH2 |
Hereditary nonpolyposis colon cancer (HNPCC) |
MLH1 3p21.3, MSH2 2p22 | |
P004-ERBB2 |
Cancer |
ERBB2 (HER2-NEU)17q21.1 |
|
P008-PMS2 |
Hereditary nonpolyposis colon cancer (HNPCC) |
PMS2 7p22 |
|
P010-POLG |
Mitochondrial maintenance |
POLG, POLG2, C10orf2 (PEO1), SLC25A4 (ANT1) |
|
P011-VWF mix 1 |
Von Willebrand Disease(vWD) |
vWF 12p13 | |
P012-VWF mix 2 |
Von Willebrand Disease(vWD) |
vWF 12p13 |
|
P013-ATRX |
Alpha-Thalassemia MentalRetardation |
ATRX ; Xq13 |
|
P014-Chromosome 8 |
Tumour research |
Chromosome 8 |
|
P015-MECP2 |
RETT syndrome |
MECP2, Xq28 | |
P016-VHL |
Von Hippel-LindauSyndrome |
VHL, 3p25 |
|
P017-MEN1 |
Multiple endocrine neoplasia |
MEN1 11q13 | |
P018-SHOX |
Idiopathic growth retardation |
SHOX-Xp22 |
|
P020 |
|||
P021-SMA |
Spinal Muscular Atrophy(SMA) |
SMN1, SMN2, 5q13 |
|
P022 -PLP1 |
Pelizaeus-Merzbacher disease (PMD) |
PLP1 Xq22 | |
P025-Canavan |
Canavan disease |
ASPA, 17p13 |
|
P026-Sotos |
Sotos syndrome |
NSD1, 5q35 |
|
P027-Uveal |
Uveal Melanoma |
1p, 3, 6p, 8q (MYC region) |
|
P028-FHL |
Familial lymphohistiocytosis(HLH) |
UNC13D 17q25.1, PRF110q22.1, STX11 6q24.2 |
|
P029-WBS |
Williams-Beuren syndrome |
WBS criticial region 7q11.23 |
|
P031-FANCA mix 1 |
Fanconi Anemia (FA) |
FANCA 16q24.3 |
|
P032-FANCA mix 2 |
Fanconi Anemia (FA) |
FANCA 16q24.3 |
|
P033-CMT1 |
Charcot-Marie Tooth disease (CMT1), Hereditary Neuropathy with liability to Pressure Palsies (HNPP) |
CMT1/HNPP region,17p11.2 |
|
P034-DMD-1 |
Duchenne MuscularDystrophy (DMD) |
DMD, Xp21.2 |
|
P035-DMD-2 |
Duchenne MuscularDystrophy (DMD) |
DMD, Xp21.2 |
|
P036-Human Telomere-3 |
Broad subtelomeric screening |
All subtelomeres |
|
P037-CLL-1 |
Chronic LymphocyticLeukemia (CLL) |
Various |
|
P038-CLL-2 |
Chronic LymphocyticLeukemia (CLL) |
Various |
|
P040-CLL |
Chronic LymphocyticLeukemia (CLL) |
Various | |
P041-ATM-1 |
Ataxia-Telangiectasia (AT) |
ATM 11q23 |
|
P042-ATM-2 |
Ataxia-Telangiectasia (AT) |
ATM 11q23 |
|
P043-APC |
Hereditary Polyposis ColonCancer |
APC, 5q21-q22 |
|
P044-NF2 |
Neurofibromatosis type 2 (NF2) |
NF2 22q12 |
|
P045-BRCA2/CHEK2 |
Breast cancer, hereditary |
BRCA2, CHEK2 |
|
P046-TSC2 |
Tuberous Sclerosis |
TSC2 16p13.3 |
|
P047-RB1 |
Retinoblastoma (RB) |
RB1 13q14 |
|
P048-LMNA/MYOT/ZMPSTE24 |
Laminopathies, Limb-girdle muscular dystrophy, Myofibrillar myopathies |
LMNA 1q21.2-1q21.3 |
|
P049-SLC6A8 - ABCD1 |
Creatine transporter, x- linked |
SLC6A8, Xq28 |
|
P050-CAH |
Congenital AdrenalHyperplasia |
CYP21A2 6p21.3 |
|
P051-Parkinson mix 1 |
Parkinson disease, familial |
PARK2 6q25.2, SNCA4q21, Pink1, Park7 1p36 |
|
P052-Parkinson mix 2 |
Parkinson disease, familial |
PARK2 6q25.2, UCHL1 |
|
P054-FOXL2-TWIST1 |
Ophthalmogenetic anomalies |
FOXL2 , TWIST1, FOXC1, FOXC2, ATR, PITX2, GPR143 |
|
P055-PAH |
Phenylketonuria |
PAH 12q24.1 |
|
P056-TP53 |
Li-Fraumeni syndrome(LFS) |
P53 17q13.1 |
|
P057-FANCD2-PALB2 |
Fanconi anemia (FA) |
FANCD2. 3p25.3, PALB216p12 |
|
P058-IGHMBP2 |
Distal spinal muscular atrophy 1 (DSMA1), SMARD1, dHMN6 |
IGHMBP2 11q13 |
|
P059-Dystonia |
Dystonia |
||
P060-SMA |
Spinal Muscular Atrophy(SMA) |
SMN1, SMN2, 5q13 |
|
P061-Lissencephaly |
Lissencephaly |
LIS1, DCX, POMT1, POMGnT1, FLNA |
|
P062-LDLR |
Hypercholesterolemia, familial |
LDLR 19p13.2 |
|
P064-MR-1 |
Mental Retardation; 1p- deletion, Williams, Smith- Magenis, Miller-Dieker, DiGeorge, Prader-Willi, Alagille, Saethre-Chotzen, Sotos |
Various |
|
P065-Marfan-1 |
Marfan syndrome |
FBN1 15q21.1, TGFBR23p22 |
|
P066-Marfan-2 |
Marfan syndrome |
FBN1 15q21.1 |
|
P067-PTCH |
Gorlin syndrome |
PTCH 9q22.3 |
|
P070-Human Telomere-5 |
Broad subtelomeric screening |
All subtelomeres |
|
P071-LMNB1-PLP1 |
Leukodystrophy |
LMNB1 5q23.2, PLP1Xq22.2, NOTCH3 19p13.12 |
|
P072-MSH6 |
Hereditary nonpolyposis colon cancer (HNPCC) |
MSH6 |
|
P074-AR |
Androgen insensitivity syndrome (AIS) |
AR Xq12 |
|
P073-IKBKG |
Incontinentia Pigmenti |
Xq28 |
|
P075-TCF4-FOXG1 |
Pitt-Hopkins syndrome, Congential variant of Rett syndrome |
TCF4, FOXG1 |
|
P076-ACADVL-SLC22A5 |
VLCAD/Primary Carnitine |
ACADVL, SLC22A5 |
|
P077-BRCA2 |
Breast cancer, hereditary |
BRCA2 |
|
P078-Breast tumour |
Breast tumour |
various |
|
P079-OTC |
Ornithine cabamoyltransferase (OTC) |
OTC Xp21.1 |
|
P080-Craniofacial |
Craniofacial disorders |
FGFRs, TWIST, MSX2, ALX4, RUNX2 |
|
P081-NF1 mix 1 |
Neurofibromatosis |
NF1 17q11.2 |
|
P082-NF1 mix 2 |
Neurofibromatosis |
NF1 17q11.2 |
|
P083-CDH1 |
CDH1 or E-cadherin |
CDH1 16q22.1 |
|
P087-BRCA1 |
Breast cancer, hereditary |
BRCA1 |
|
P088-Oligodendroglioma |
Oligodendroglioma |
1p, 19q |
|
P089-TK2 |
mtDNA depletion syndrome |
TK2, MPV17, DGUOK, RRM2B, SUCLA2, SUCLG1 |
|
P090-BRCA2 |
Breast cancer, hereditary |
BRCA2 13q12.3 |
|
P091-CFTR |
Cystic Fibrosis |
CFTR 7q31.2 |
|
P092-ABCC6 |
Pseudoxanthoma elasticum |
ABCC6 16p13.1 |
|
P093-HHT/PPH1 |
Hemorrhagic telangiectasia, hereditary (HHT), Primary pulmonary hypertension (PPH1) |
ENG 9q34.1, ALK112q13.13, BMPR2 2q33.3 |
|
P094-MEFV |
Mediterranean fever, familial(MEFV) |
MEFV 16p13.3 |
|
P095-Aneuploidy |
Down syndrome, Edwards syndrome, Patau syndrome |
Chr. 13, 18, 21, X, Y |
|
P096-MR-2 |
Mental retardation, Wolf- Hirschlorn, Cri du Chat, Langer-Giedon, WAGR, Rubinstein-Taybi, Down, Kabuki |
Various |
|
P098-Wilson |
Wilson disease |
ATP7B 13q14.3 |
|
P099-GCH1-TH-SGCE |
Dopa-responsive dystonia, Segawa disease; Myoclonus-dystonia syndrome |
TH 11p15.5, GCH114q22, SGCE 7q21 |
|
P100-MYBPC3 |
Hypertrophic cardiomyopathy, familial |
MYBPC3 11p11.2 |
|
P101-STK11 |
Peutz-Jeghers syndrome(PJS) |
STK11 19p13.3 |
|
P102-HBB |
Thalassemia, beta-zero |
HBB 11p15.5 |
|
P103-DPYD |
Dihydropyrimidine dehydrogenase (DPYD) deficiency |
DPYD 1p22 |
|
P104-Menkes ATP7A |
Menkes disease |
ATP7A Xq13.3 |
|
P105-Glioma-2 |
Glioma, malignant |
EGFR, TP53, PTEN +various other |
|
P106-MRX |
Mental retardation, x-linked(XLMR) |
Chromosome X |
|
P107-Neurometabolic |
Neurometabolic disorders |
ASPA, MLC1, MLYCD, D2HGDH, L2HGDH |
|
P108-SCN5A |
Brugada / long QT |
SCN5A 3p22 |
|
P109-ABCB4 |
Drug-transport pump |
ABCB4 7q21,1 |
|
P110-FCGR mix 1 |
FCGR genes 1q23.3 |
FCGR genes 1q23.3 |
|
P111-FCGR mix 2 |
FCGR genes 1q23.3 |
FCGR genes 1q23.3 |
|
P112-PROS1 |
PROS1 deficiency |
PROS1 3q11.2 |
|
P113-FANCB |
Fanconi anemia complementation group B |
FANCB Xp22 |
|
P114-Long-QT |
Congenital long QTsyndrome (LQT) |
KCNQ1 11p15.5, KCNH27q35 |
|
P116-SGC |
Limb-girdle muscular dystrophy (LGMD) |
SGCA, SGCB, SGCD, SGCG, FKRP |
|
P117-ABCC8 |
Hyperinsulinemic hypoglycemia, familial (HHF1) |
ABCC8 11p15.1 |
|
P118-WT1 |
Wilms tumours, WAGR, Denys-Drash, Frasier syndrome. |
WT1 11p13 |
|
P120-PANK2/PLA2G6 |
Neurodegeneration with brain iron accumulation (NBIA) |
PANK2 20q13, PLA2G622q13 |
|
P122-NF1-area |
Neurofibromatosis |
NF1 17q11.2 |
|
P124-TSC1 |
Tuberous Sclerosis |
TSC1 9q34 |
|
P125-Mitochondria |
Mitochondrial DNA (mtDNA) |
Mitochondria |
|
P128-CYP450 |
Cytochrome P-450 |
CYP2D6, CYP2C9, CYP2C19, CYP1B1, |
|
P130-CCM mix-A |
Cerebral CavernousMalformations (CCM) |
CCM 7q21 |
|
P131-CCM mix-B |
Cerebral CavernousMalformations (CCM) |
CCM 7q21 |
|
P132-Kallmann-1 |
Kallmann syndrome, x- linked |
KAL1 Xp22 |
|
P133-Kallmann-2 |
Kallmann syndrome |
FGFR1 8p11.2, GNRHR8p21, KISSR1 19p13.3 , GNRH1, NELF 9q34.3 |
|
P136-Gitelman |
Gitelman syndrome |
SLC12A3 16q13 |
|
P137-SCN1A |
Epilepsy |
SCN1a 2q24.3 |
|
P138-SLC2A1 |
Glut1 deficiency syndrome |
SLC2A1 1p34.2 |
|
P140-HBA |
Thalassemias, Alpha |
HBA 16p |
|
P141-NIPBL-1 |
Cornelia de Lange syndrome (CDLS) |
NIPBL 5q13.1 |
|
P142-NIPBL-2 |
Cornelia de Lange syndrome (CDLS) |
NIPBL 5q13.1 |
|
P143-MFN2-MPZ |
Charcot-Marie-Tooth disease (CMT2A/1B) |
MFN2 1p36.2, MPZ 1q22 |
|
P147-1p36 |
1p36 deletion syndrome |
1p36 |
|
P148-TGFBR1-TGFBR2 |
Aortic aneurysm syndrome |
TGFBR1 9q22, TGFBR23p22 |
|
P149-CYP4V2 |
Crystalline Corneoretinal |
CYP4V2 |
|
P151-ABCA4 mix-1 |
Stargardt, Macular dystrophy, Retinitis pigmentosa, age-related macular degeneration |
ABCA4 (ABCR) 1p22.1 |
|
P152-ABCA4 mix-2 |
Stargardt, Macular dystrophy, Retinitis pigmentosa, age-related macular degeneration |
ABCA4 (ABCR) 1p22.1 |
|
P153-EYA1 |
Branchio-oto-renal dysplasia syndrome (BOR) |
EYA1 8q13.3. |
|
P154-GPC3-GPC4 |
Simpson-Golabi-Behmel syndrome (SGBS) |
GPC3, GPC4, Xq26 |
|
P155-EDS |
The Ehlers-Danlos syndrome type III (EDS III) |
COL3A1 2q31, TNXB6p21.3. |
|
P156-GALT |
Classic galactosemia |
GALT 9p13 |
|
P158-JPS |
Juvenile polyposis syndrome (JPS) |
BMPR1A 10q22, SMAD418q21, PTEN |
|
P159-GLA |
Fabry Disease |
GLA Xq22 |
|
P160-STS |
Steroid Sulfatase gene(STS) |
STS Xp22 |
|
P163-GJB-WFS1 |
Hearing loss |
GJB 1p35.1 (connexin 31), WFS1 4p16.1 (Wolframin) |
|
P164-IDS |
Mucopolysaccharidosis typeII, or Hunter syndrome |
IDS Xq28 |
|
P165-HSP |
Spastic paraplegia, hereditary (HSP) |
SPG3A 14q21, SPAST2p22 |
|
P166-KCNQ2 |
Benign familial neonatal convulsion (BFNC) |
KCNQ2 20q13.33 |
|
P168-ARVC-PKP2 |
Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C) |
DSP 6p24, PKP2 12q11.21 |
|
P169-Hirschsprung-1 |
Hirschsprung disease, orAganglionic Megacolon |
RET 10q11.2, ZFHX1B2q22.3, EDN3 20q13.3 andGDNF 5q13.2 |
|
P170-APP |
Alzheimer disease, early- onset |
APP 21q21.3 |
|
P175-Tumour-Gain |
Tumour-gain |
various |
|
P176-CAPN3 |
Limb girdle muscular dystrophy 2A (LGMD2A) |
CAPN3 15q15.1 |
|
P177-CASR |
HypocalciuricHypercalcemia, familial |
CASR 3q13 |
|
P178-F8 |
Haemophilia A, x-linked |
F8 gene, Xq28 |
|
P179-Limb-1 |
Limb malformations |
GLI3 7p13, HOXD13 2q31, ROR2 9q22 |
|
P180-Limb-2 |
Limb malformations, heart |
SALL1 16q12, SALL420q13, TBX5 12q24 |
|
P181-Centromere-1 |
Centromeric screening |
Centromeres |
|
P182-Centromere-2 |
Centromeric screening |
Centromeres |
|
P183-EDA |
Ectodermal dysplasia, x- linked (XLHED) |
EDA Xq12-q13.1 |
|
P184-JAG1 |
Alagille Syndrome (AGS) |
JAG1 20p12.2 |
|
P185-Intersex |
Sex determination |
SOX9 17q24.3, NR5A19p33, WNT4 1p36.12, NROB1 Xp21.2 |
|
P186-PAX3-MITF-SOX10 |
Waardenburg syndrome(WS) type II, WS1, WS3 |
PAX3 2q35, MITF 3p14, SOX10 22q13.1 |
|
P187-HPE |
Holoprosencephaly (HPE) |
PTCH, SHH, ZIC2, SIX3, |
|
P188-22q13 |
Phelan-Mcdermid syndrome, Telomeric monosomy 22q13.3 |
22q13.3, SHANK3, ACR, RABL2B |
|
P189-CDKL5 |
Rett syndrome, atypical |
CDKL5 Xp22, NTNG11p13.3, ARX Xp22.1 |
|
P190-CHEK2 |
Breast cancer susceptibility |
CHEK2 22q12, ATM , PTEN, TP53 |
|
P191-Alport-mix1 |
Alport syndrome, HereditaryNephritis |
COL4A5 Xq22 |
|
P192-Alport-mix2 |
Alport syndrome, HereditaryNephritis |
COL4A5 Xq22 |
|
P193-NPC1 |
Niemann-Pick type Cdisease (NPC) |
NPC1, NPC2 |
|
P196-TNNT2-BAG3 |
Hypertrophic cardiomyopathy familial, Dilated cardiomyopathy |
TNNT2 1q32 |
|
P197-KCNQ3 |
Neonatal convulsions type2, familial (BFNC2), Epilepsy benign neonatal type 2 (EBN2) |
KCNQ3 8q24.22 |
|
P198-FH |
Fumarase deficiency (FH) |
FH |
|
P199-HEXA |
Tay-Sachs Disease |
HEXA 15q23 |
|
P200-Reference-1 |
Synthetic 'home-made' probes |
Reference probes + control fragments |
|
P201-Charge |
Charge syndrome |
CHD7 8q12.2 |
|
P202-IKZF1 (IKAROS) |
Acute lymphoplastic leukemia (ALL), CML |
IKZF1 7p12.2 |
|
P203-PKLR |
Haemolytic Anaemia, hereditary non-spherocytic |
PKLR 1q22 |
|
P205-XLP |
Lymphoproliferative syndrome, x-linked (XLP). Duncan disease |
SH2D1A Xq25 |
|
P207-F9 |
Factor IX deficiency, Christmas disease |
F9 Xq27.1 |
|
P208-Human Telomere-6 |
Subtelomeric screening |
2p, 3p, 6p, 8p |
|
P209-GLDC |
Glycine encephalopathy |
GLDC 9p22 |
|
P210-BTK |
Agammaglobulinemia |
BTK Xq22.1 |
|
P211-HSP region |
Hereditary SpasticParaplegias (HSPs) region |
SPAST 2p22, NIPA1 15q11 |
|
P212-DBA |
Diamond-Blackfan anemia(DBA) |
RPS19 19q13.2, 8p23 |
|
P213-HSP2 |
Hereditary spastic paraplegias (HSPs) |
REEP1 (SPG31) 2p11.2, SPG7 16q24.3 |
|
P214-COL2A1 |
Skeletal disorders, Achondrogenesis, Chondrodysplasia, Early onset familial Osteoarthritis, SED congenital, Langer- Saldino achondrogenesis, Kniest dysplasia, Stickler syndrome, Spondyloepimetaphyseal |
COL2A1 12q13.11-q13.2 |
|
P215-EXT |
Multiple Osteochondromas |
EXT1 8q24, EXT2 11p12 |
|
P216-GHD mix1 |
Growth Hormone Deficiency(GHD) |
GH1, LHX4, POU1F1, HESX1, PROP1, GHRHR, LHX3 |
|
P217-IGF1R |
Insulin-like growth factor 1 receptor (IGF1R) |
IGFR1, IGFBP3. |
|
P218-LPL |
LPL deficiency |
LPL 8p21.3 |
|
P219-PAX6 |
Ocular malformations, hereditary |
PAX6 11p13, SOX2 3q26, WT1, 11p13 |
|
P220-Obesity |
Obesity |
LEPR, POMC, LEP, SIM1, MC3R, MC4R |
|
P221-LCA mix-1 |
Leber congenital amaurosis(LCA) |
AIPL1 17p13, CRB1 1q31, CRX 19q13, RPE65 1p31 |
|
P222-LCA mix-2 |
Leber congenital amaurosis(LCA) |
GUCY2D 17p13.1, RDH1214q24, RPGRIP1 14q11, CEP290 12q21 |
|
P223-PHEX |
Hypophosphatemia, x-linked |
PHEX Xp22.2, FGF2312p13 |
|
P224-PPARG |
Obesity, Diabetes mellitis type II, Familial partial lipodystrophy III, Colon cancer |
PPARG 3p25.1 |
|
P225-PTEN |
Cancer |
PTEN 10q23 |
|
P226-SDH |
Paragangliomas (PGL) |
SDHD 11q23.1, SDHB1p36.1, SDHC 1q23.3 |
|
P227-SerpinC1 |
Antithrombin (III) deficiency |
SerpinC1 1q25.1 |
|
P228-TRPS1-EXT1 |
Trichorhinophalangeal syndrome type I (TRPS1), Langer-Giedion syndrome (LGS) |
TRPS1, EXT1, 8q24 |
|
P229-OPA1 |
Macular dystrophy |
OPA1 3q28, VMD2 11q13, RDS 6p21.2 |
|
P231-FGF10-FGFR2 |
Autosomal dominant lacrimoauriculodentodigital (LADD) |
FGF10 5p13, FGFR2 10q26 |
|
P232-FGD1 |
Faciogenital dysplasia (FGDY), Aarskog-Scott syndrome |
FGD1 Xp11.21 |
|
P233-MID1 |
OPITZ syndrome |
MID1 Xp22 |
|
P234-GATA4 |
Cardiac septal defects |
GATA4 8p23, GATA310p15 |
|
P235-Retinitis |
Retinitis Pigmentosa |
RHO 3q21.3, RP1 8q11.2, IMPDH1 7q32, PRPF3119q13.4 |
|
P236-ARMD mix-1 |
Age-related macular degeneration (ARMD) |
CFH, CFHR3, CFHR1, CFHR2, 1q23 |
|
P238-DNAH5 |
Primary ciliary dyskinesia(PCD) |
DNAH5 5p15 |
|
P239-BRCA1 region |
Breast cancer |
BRCA1 region |
|
P240-BRIP1/CHEK1 |
Cancer |
BRIP1 17q22, CHEK111q22 |
|
P241-MODY |
Maturity-Onset Diabetes of the Young (MODY) |
MODY 1, 2, 3; 5 |
|
P242-Pancreatitis |
Hereditary Pancreatitis (HP) |
PRSS1 7q34, SPINK1 5q32 |
|
P243-SERPING1 |
Hereditary angioedema(HAE) |
SERPING1 11q12.1 |
|
P244-AIP-MEN1 |
Multiple endocrine neoplasia (MEN) |
AIP 11q13, MEN1 11q13 |
|
P245-Microdeletion-1 |
Microdeletion syndromes |
Various |
|
P247-Chemokine-2 |
Chemokines |
CXCR4, CX3CR1, CCR5, CCR2, CD4, CD209 |
|
P248-MLH1-MSH2 |
Colon cancer, hereditary non-polyposis (HNPCC) |
MLH1 3p21.3, MSH2 2p21 |
|
P249-Human Telomere-8 |
Subtelomeric screening |
17p, 18p, 19p, 20p |
|
P250-DiGeorge |
DiGeorge syndrome |
22q11 |
|
P251-NB mix 1 |
Neuroblastoma |
1p36, 3p22/3p21.3 and11q23 |
|
P252-NB mix 2 |
Neuroblastoma |
2p24.1/MYCN, 2q33,17p13/TP53, 17q |
|
P253-NB mix 3 |
Neuroblastoma |
Chromosomes 4, 7, 9, 12,14 |
|
P254-PSEN1 |
Alzheimer's disease (AD) |
PSEN1 14q24.2 |
|
P255-ALDOB |
Fructose intolerance |
ALDOB 9q21 |
|
P256-FLCN |
Birt-Hogg-Dube syndrome |
FLCN 17p11, Smith- Magenis syndrome region |
|
P257-TERT-DKC1 |
Dyskeratosis congenita(DC) |
DKC1 Xq28 |
|
P258-SMARCB1 |
Rhabdoid tumors |
SMARCB1 22q11.2 |
|
P259-RPS6KA3 |
Coffin-Lowry Syndrome(CLS) |
RPS6KA3, PQBP1. |
|
P260-PALB2-RAD50-RAD51C |
Fanconi Anemia |
RAD50 |
|
P262-GHI |
Growth HormoneInsensitivity (GHI) |
GHR 5p12, JAK2 9q24.1, IGF1 12q23, STAT5B17q21 |
|
P264-Human Telomere-9 |
Subtelomeric screening |
1q, 2q, 3q, 4q |
|
P266-CLCNKB |
Bartter syndrome |
CLCNKB 1p36 |
|
P267-Dandy-Walker |
Dandy-Walker Malformation(DWM) |
ZIC1, ZIC4 3p2, VLDLR9p24 |
|
P268-DYSF |
Limb girdle muscular dystrophies (LGMD) |
DYSF 2p13 |
|
P269-FRMD7 |
Congenital nystagmus |
Xq26 (NYS1 locus), FRMD7 |
|
P271-COL1A1 |
Osteogenesis imperfecta(OI) |
COL1A1 17q21.3 |
|
P272-COL1A2 |
Osteogenesis imperfecta(OI) |
COL1A2 7q21.3 |
|
P274-SLC6A5/GLRA1/GLRB |
Startle disease, Hyperekplexia |
GLRB 4q32.1, GLRA15q33.1, SLC6A5 11p15.1 |
|
P275-MAPT-GRN |
Alzheimer's disease, Pick's disease, frontotemporal dementia, cortico-basal degeneration, progressive supranuclear palsy |
MAPT 17q21 |
|
P277-Human Telomere-10 |
Subtelomeric screening |
5q, 6q, 7q, 8q |
|
P278-PCCA |
Propionic acidemia |
PCCA 13q32 |
|
P279-CACNA1A |
Episodic ataxia 2, Familial hemiplegic migraine |
CACNA1A |
|
P280-SLC26A4 |
Pendred syndrome |
SLC26A4 7q31 |
|
P285-LRP5 |
Osteopoprosis- pseudoglioma syndrome (OPPS) |
LRP5 11q13.4, DKK110q11.2 |
|
P286-Human Telomere-11 |
Subtelomeric screening |
9q, 10q, 11q, 12q |
|
P289-LMX1B |
Nail patella syndrome (NPS) |
LMX1B 9q33 |
|
P292-PCDH15 |
Usher syndrome |
PCDH15 10q21.1 |
|
P294-Tumour-Loss |
Tumour-Loss |
various |
|
P295-SPRED1 |
SPRED1 |
SPRED1 15q14 |
|
P296-aHUS |
Hemolytic uremic syndrome, typical (aHUS) |
CFH 4q25 |
|
P297-Microdeletion-2 |
Microdeletion syndromes |
Various |
|
P300-Reference-2 |
Synthetic 'home-made' probes |
Reference probes + control fragments |
|
P301-Medulloblastoma mix 1 |
Medulloblastoma |
Chr. 6, Chr. 14, Chr. 16, Chr. 17. |
|
P302-Medulloblastoma mix 2 |
Medulloblastoma |
Chr. 2, Chr. 3, Chr. 7, Chr. 9 |
|
P303-Medulloblastoma mix 3 |
Medulloblastoma |
Chr. 1, Chr. 4, Chr. 5, Chr.8, Chr. 10, Chr. 20 |
|
P304-IRF6 |
Van der Woude syndrome(VWS) |
IRF6 1q32.2 |
|
P305-AGXT |
Primary hyperoxaluria, type1 (PH1) & type 2 (PH2) |
AGXT, GRHPR |
|
P306-SPG11 |
Hereditary spastic paraplegia (HSP or SPG) |
SPG11 or KIAA184015q21.1 |
|
P307-SEPT9 |
Hereditary neuralgic amyotrophy (HNA) |
SEPT9 17q25.3 |
|
P309-MTM1 |
Myotubular myopathy, x- linked (XLMTM) |
MTM1 Xq28, MTMR1 Xq28 |
|
P310-TCOF1 |
Treacher Collins- Franceschetti 1 |
TCOF1 |
|
P311-CHD |
Congenital Heart Disease(CHD) |
GATA4 8p23, NKX2-5 5q35, TBX5 12q24, BMP4 14q22, CRELD1 3p25 |
|
P312-POR |
Congenital adrenal hyperplasia (CAH) |
P450 oxireductase gene(POR) |
|
P313-CREBBP |
Rubinstein-Taybi syndrome(RSTS) |
CREBBP 16p13.3 |
|
P315-EGFR |
Tumours, solid |
EGFR 7p11 |
|
P316-Ataxias |
Recessive Ataxias |
SETX, APTX, FXN. |
|
P318-Hirschsprung-2 |
Hirschsprung disease |
PHOX2B, GFRA3, GFRA2, GFRA1, EDNRB, NRTN, PSPN, SOX10 |
|
P320-Human Telomere-13 |
Subtelomeric screening |
17q, 18q, 19q, 20q. |
|
P321-VPS13B mix 1 |
Cohen syndrome |
VPS13B 8q22 |
|
P322-VPS13B mix 2 |
Cohen syndrome |
VPS13B 8q22 |
|
P323-CDK4-HMGA2-MDM2 |
Sarcoma and other tumour types |
chromosome 12, MDM2, CDK4 and HMGA2 genes |
|
P324-22q11 mix-2 |
22q11 |
22q11 |
|
P325-OCA2 |
oculocutaneous albinism |
OCA2 15q13 |
|
P326-LARGE |
Walker-Warburg Syndrome |
LARGE, FKTN, POMT2 |
|
P327-iAMP21 |
ALL, iAMP21, ERG |
iAMP21, RUNX1, ERG |
|
P328-EYS |
Retinitis Pigmentosa |
EYS 6q12 |
|
P329-CRLF2 |
ALL |
Xp22.33 |
|
P330-PCDH19 |
Epilepsy (EFMR) |
PCDH1 |
|
P331-COL5A1 MIX-1 |
Ehlers-Danlos Syndrome |
COL5A1 9q34.3 |
|
P332-COL5A1 MIX-2 |
Ehlers-Danlos Syndrome |
COL5A1 9q34.3 |
|
P333-EP300 |
Rubinstein-Taybi syndrome(RSTS) |
EP300 |
|
P334-Gonadal |
Gonadal DevelopmentDisorder |
DMRT1, CYP17A1, SRD5A2, HSD17B3 |
|
P335-ALL-IKZF1 |
ALL |
IKZF1, PAX5, ETV6, RB1, BTG1, EBF1, CDKN2A- CDKN2B, Xp22.33 |
|
P336-UBE3A |
Angelman |
UBE3A, MTHFR, GABRB3, AXIN1 |
|
P337-TSC2 |
Tuberous sclerosis |
TSC2 gene, 16p13.3 |
|
P339-SHANK3 |
Autism Spectrum Disorder |
SHANK3 22q13.33 |
|
P340-EHMT1 |
9q subtelomeric deletion syndrome (9qSTDS) or Kleefstra syndrome. |
EHMT1 |
|
P341-PKHD1 mix 1 |
Polycystic kidney disease, autosomal recessive (ARPKD) |
PKHD1 |
|
P342-PKHD1 mix 2 |
Polycystic kidney disease, autosomal recessive (ARPKD) |
PKHD1 |
|
P343-Autism-1 |
Autism |
15q11-13: UBE3A, GABRB3; 16p11; SHANK322q13 |
|
P348-ATP1A2-CACNA1A |
Migraine |
1q23 |
|
P350-CLCN1-KCNJ2 |
Myotonia congenita, Thomsen's disease, Becker's disease, Andersen-Tawil syndrome |
CLCN1, KCNJ2 |
|
P351-PKD1 |
Adult polycystic kidney disease |
PKD1 |
|
P352-PKD1-PKD2 |
Adult Polycystic Kidney |
PKD1, PKD2 |
|
P353-CMT4 |
autosomal recessive demyelinating form |
SH3TC2; NEFL; GDAP1; EGR2; SBF2; MTMR2; PRX |
|
P354-KIT SNAI2 |
Piebaldism/KIT |
||
P355-Microcephaly |
Primary Microcephaly |
MCPH1, ASPM, |
|
P356-Chromosome 22q |
Subtelomeric screening |
22q11, 22q13 |
|
P357-MODY mix-2 |
Maturity-Onset Diabetes of the Young (MODY) |
MODY 4; 6-10 |
|
P359-PLOD1 |
Ehlers Danlos syndrome type VI |
1p36.22 |
|
P360-Y-Chromosome |
Y-ChromosomeMicrodeletions |
Chromosome Y |
|
P361-USH2A mix 1 |
Usher syndrome |
USH2A 1q41 |
|
P362-USH2A mix 2 |
Usher syndrome |
USH2A 1q41 |
|
P365-Human Telomere-14 |
Subtelomeric screening |
7p, 15q-cen, 16p, 21q-cen,21q |
|
P366-CHM-RP2-RPGR |
Retinitis pigmentosa (RP) |
CHM-RP2-RPGR |
|
P367-BEST1-PRPH2 |
Macular Dystrophy, Vitelliform |
BEST1 (=VDM2), PRPH2 (=RDS) |
|
P368-DCLRE1C |
SCID and Omenn syndrome |
10p13; DCLRE1C |
|
P369-Smith-Magenis |
Smith-Magenis syndrome |
17p11.2 |
|
P370-BRAF-IDH1-IDH2 |
Gliomas |
BRAF, IDH1, IDH2 |
|
P371-Microdeletion-5 |
Microdeletion follow-up |
2p16, Langer Giedion,9q22, WAGR, 15q24, 17q21 |
|
P372-Microdeletion-6 |
Microdeletion follow-up |
Sotos, DiGeorge, Rubinstein-Taybi, NF1 |
|
P373-Microdeletion-7 |
Microdeletion follow-up |
1p36, 3q29, Wolf- Hirschlorn, Cri du Chat, Phelan-McDermid |
|
P374-Microdeletion-8 |
Microdeletion follow-up |
7q11, PWS/AS, Miller- Dieker, Smith-Magenis, RETT |
|
P376-BRCA1ness |
BRCA1-like breast cancer profile |
various |
|
P377-Hematologic malign. |
Hematological malignancies, various |
various |
|
P378-MUTYH |
Colon cancer, stomach cancer (hereditary) |
1p34 and 15q13 |
|
P379-NRXN1 |
Pitt-Hopkins-like syndrome2 |
NRXN1 |
|
P381-COL11A1 mix 1 |
Marshall, type II Stickler syndromes |
COL11A1 |
|
P382-COL11A1 mix 2 |
Marshall, type II Stickler syndromes |
COL11A1 |
|
P385-DOCK8 |
HIES |
9p24.3 |
|
P386-DOCK8 STAT3 |
HIES |
17q21.2, 9p24.3 |
|
P387-NPHP1 |
Familial juvenile nephronophthisis |
NPHP1 2q13 |
|
P389-MLL2 |
Kabuki syndrome |
MLL2 gene |
|
P391-LAMA2 mix1 |
CMD, Merosin-deficient |
6q22.33 |
|
P392-LAMA2 mix2 |
CMD, Merosin-deficient |
6q22.33 |
|
P394-MYO5B |
Microvillus InclusionDisease (MVID) |
MYO5B 18q21.1 |
|
P395-MEF2C-FOXG1 |
mental retardation |
MEF2C 5q14.3, FOXG114q12 |
|
P396-SHANK2 |
Autism-spectrum disorder |
SHANK2 11q13.3 |
|
P397-SCN4A-CACNA1S |
nondystrophic myotonias and primary periodic paralyses |
CACNA1S, SCN4A |
|
P398-CASK |
X-linked mental retardation and MICPCH |
CASK |
|
P405-CMT1 |
Charcot Marie ToothDisease |
CMT/HNPP region at 17p12 |
|
P408-ADLTE-LGI1 |
Autosomal Dominant Lateral Temporal Lobe Epilepsy, ADLTE |
ADAM22, GPR98, KCNA1, KCNA4, KCNAB1, LGI1, PDYN |
|
P409-RASA1 |
capillary malformations, Parkes Weber syndrome |
RASA1 5q14.3 |
|
P410-GRIN2A GRIN2B |
epilepsy, mental retardation |
16p13.2 GRIN2A, 12p13.1GRIN2B |
|
P411-Porphyria mix 1 |
Porphyrias |
ALAD, HMBS, PPOX |
|
P412-Porphyria mix 2 |
Porphyrias |
FECH, UROS, UROD, CPOX |
|
P413-CRC LOSS |
Colorectal adenoma/carcinoma |
8p, 15q, 17p, 18q |
|
P414-MDS |
Myelodysplastic syndromes |
3, 5q,7q, 8q, 11q, 12p, 17, 19, 20q, Y |
|
P417-BAP1 |
Melanocytic tumours, mesothelioma |
3p21.1 |
|
P418-MYH7 |
Hypertrophic cardiomyopathy |
MYH7 14q11.2 |
|
P419-CDKN2A/2B-CDK4 |
Familial melanoma |
CDKN2A, CDKN2B, CDK4, MITF E318K |
|
P425-MM |
Multiple myeloma |
various |
|
P426-Cystinuria |
Cystinuria and hypotonia-cystinuria syndrome |
SLC3A1, PREPL, SLC7A9 |
|
P431-FOXF1 |
Alveolar capillary dysplasia with Misalignment of pulmonary veins and Feingold syndrome |
FOXF1 |
|
P436-ANO5 |
Muscular dystrophy type 2L or Anoctaminopathy |
ANO5 |
|
P437-MDS-AML |
Familial Myelodysplastic Syndrome and Acute Myeloid Leukemia |
GATA2, TERC, TERT, CEBPA, RUNX1 |
|
P444-COL4A4 |
Alport syndrome or Hereditary nephritis |
COL4A4 |
|
P446-GALC |
Krabbe disease |
GALC 14q31.3 |
|
P452-PLS3 |
X-linked osteoporosis |
PLS3 Xq23 |
|
P457-DHCR7 |
Smith-Lemli-Opitz syndrome (SLOS) |
DHCR7 |
|
P461-DIS |
Deafness-infertility syndrome, Autosomal recessive deafness 16 and Autosomal recessive deafness 22 |
STRC, CATSPER2, OTOA |
|
P466-CDC73 |
Familial primary hyperparathyroidism |
CDC73 |
|
P482-DICER1 |
DICER1 syndrome |
DICER1 |
|
P484-ALPL |
Hypophosphatasia |
ALPL |
|
X080 Opsin |
Cone photoreceptor disorders |
OPN1MW |